Drug Database
Back to search

Norway· NO-ID_547CBB79-28EF-4ECE-8769-101DFFCD008B

Pyrazinamide jenapharm

A pyrazinamide product containing pyrazinamid, registered in Norway by Jenapharm GmbH & Co. KG. The same ATC class is registered in 14 of our 19 countries.

ATC J04AK01

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedPyrazinamide jenapharmATCJ04AK01REGISTER NO.NO-ID_547CBB79-28EF-4…PACKS LISTED3CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about pyrazinamidAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Pyrazinamide is registered in 14 of 19 countries.

Countries holding a registration under ATC J04AK01 (pyrazinamide), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 8 of them publish a price we can compare per daily dose
Search pyrazinamide products by name

Pyrazinamide · ATC J04AK01

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pyrazinamide costs, country by country.

Normalised to the WHO defined daily dose (1.5 g), the median price runs from $0.61 in France to $3.20 in Switzerland — a ×5.2 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Pyrazinamide · price per daily dose (1.5 g)

USD · FX 28 Sept 2026

  • CH Switzerland$3.20
  • FR France$0.61
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FEST (Norway)
Active substance
Pyrazinamid
Manufacturer
Jenapharm GmbH & Co. KG
Country
Norway (NO)
ATC code
J04AK01
ATC class
Pyrazinamide
Defined daily dose
1.5 g, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

  • no_merkevare_id
    ID_547CBB79-28EF-4ECE-8769-101DFFCD008B
  • no_varenummer
    267328
    100
  • gtin
    4150044335524

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

81 interactions on record for pyrazinamide.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check pyrazinamide against other medicinesHow interaction checks work

Pyrazinamide · interactions on record

81 records

  • 4 severe
  • 19 moderate
  • 54 info

Most severe, free to view

  • LeflunomidL04AA13severe
  • TeriflunomidL04AA31severe
  • LeflunomideL04AK01severe
  • TeriflunomideL04AK02severe

4 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pyrazinamide in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pyrazinamide products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Pyrafat
  • Belgium · Tebrazid
  • Bulgaria · Пиразинамид Крка
  • Germany · Pyrafat, Pyrazinamid Jenapharm
  • Denmark · Pyrazinamid Sad
  • Spain · Pirazinamida Prodes
  • Finland · Tisamid
  • France · Pirilene
  • United Kingdom (Northern Ireland) · Pyrazinamide Morningside Healthcare
  • Greece · Pyrazinamide Genepharm
  • Croatia · Pyrazinamid Krka
  • Lithuania · Pyrafat, Pyrazinamide Krka
  • Luxembourg · Tebrazid
  • Latvia · Pyrazinamide Olpha
  • Malta · Pyrazinamide Morningside Healthcare
  • Netherlands · Pyrazinamide Cf
  • Poland · Pyrazinamid Farmapol
  • Portugal · Pramide
  • Romania · Pirazinamida Atb
  • Slovenia · Pirazinamid Krka

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b561c453-443d-46e9-b564-d539309738e0
GET /v1/drugs/b561c453-443d-46e9-b564-d539309738e0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablett",
  "source": "fest",
  "status": "A",
  "atc_name": "Pyrazinamid",
  "merkevare_id": "ID_547CBB79-28EF-4ECE-8769-101DFFCD008B",
  "name_form_strength": "Pyrazinamide jenapharm tab 500 mg",
  "prescription_group": "C"
}
API referenceMCP serverPlans

See everything about pyrazinamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console